Company Profile

Accelrys (AKA: BIOSYM Technologies Inc)
Profile last edited on: 1/31/17      CAGE:       UEI:

Business Identifier: Software for chemical, materials and bioscience research for the pharmaceutical, biotechnology, consumer packaged goods, aerospace, energy and chemical industries
Year Founded
1984
First Award
1985
Latest Award
1993
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

9685 Scranton Road
San Diego, CA 92121
   (619) 546-5517
   N/A
   N/A
Location: Single
Congr. District: 52
County: San Diego

Public Profile

In January 2014, Accelrys was acquired by 3D software vendor Dassault Systèmes (France). Previously doing business as Biosym Technologies, in June 1992, BioSym had originally been acquired by Corning and operated as a wholly owned subsidiary. In August 1995, Biosym Technologies, Inc. was then acquired by Accelrys Inc. a Scientific Informatics software and services company for life sciences, chemical and materials R&D enabling customers to both accelerate their research process to more rapidly discover new therapeutics, materials and compounds; and to introduce new efficiencies into the process that drive lower costs. In February 2004, Accelrys went public with stock sysmbol Nasdaq: ACCL. The firm then went on to make a number of acquisitions raising the total employment of the firm to over 750 people

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
500+
Revenue Range
Over 50M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Richard M Fine

  Judith C Hempel

  Richard H Lee

  Donald Mackay

  Eva Meirovitch

  Thomas S Thacher

Company News

There are no news available.